Light therapy shows promise for brain health in sickle cell kids
NCT ID NCT06797583
First seen Dec 08, 2025 · Last updated Jun 19, 2026 · Updated 32 times
Summary
This study tests a new, non-invasive light therapy (transcranial photobiomodulation) to see if it can improve brain function in children with sickle cell disease. Sickle cell can reduce oxygen to the brain, causing thinking and learning problems. The study will randomly assign 60 children (ages 8-17) to receive either active light therapy or a placebo, and measure changes in cognitive performance and brain oxygen levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.